Broomfield, CO, May 8, 2011 — Ariel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative drugs for acute neurological diseases and trauma, today announced that Dr. Steve Orndorff, President and Chief Executive Officer, will present at the 6th Annual Neurotech Investing & Partnering Conference at the St. Regis Hotel in San Francisco. The presentation is scheduled for Monday, May 9, 2011 at 3:30 pm PT. Dr. Orndorff will be discussing drug development opportunities for orphan neurological disorders based upon common genetic or physiological traits across related diseases.